CHINA / SOCIETY
China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response: The Lancet
Published: Jul 20, 2020 10:17 PM

Vaccine file photo:Xinhua


 
A phase 2 trial of a COVID-19 vaccine candidate conducted in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
blog comments powered by Disqus